For research use only. Not for therapeutic Use.
<p>
<span style="font-size:12px;"><span style="font-family:arial,helvetica,sans-serif;">trans-Resveratrol 4’-O-β-D-Glucuronide(CAS </span></span>387372-20-5) <span style="font-family: arial, helvetica, sans-serif;">is a phase II metabolite of the antioxidant </span><em style="box-sizing: border-box; font-family: LatoLight; font-size: 16px;">trans</em><span style="font-family: arial, helvetica, sans-serif;">-resveratrol. </span><em style="box-sizing: border-box; font-family: LatoLight; font-size: 16px;">trans</em><span style="font-family: arial, helvetica, sans-serif;">-Resveratrol-4'-O-D-glucuronide is formed</span><span style="font-family: arial, helvetica, sans-serif;"> via glucuronidation of </span><em style="box-sizing: border-box; font-family: LatoLight; font-size: 16px;">trans</em><span style="font-family: arial, helvetica, sans-serif;">-resveratrol by the UDP-glucuronosyltransferase (UGT) isoform UGT1A9.</span></p>
Catalog Number | R011212 |
CAS Number | 387372-20-5 |
Synonyms | 4-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]phenyl β-D-Glucopyranosiduronic Acid; Resveratrol 4’-O-Glucuronide; |
Molecular Formula | C20H20O9 |
Purity | ≥95% |
Target | FATP |
Storage | 4°C |
IUPAC Name | 6-[4-[2-(3,5-dihydroxyphenyl)ethenyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid |
InChI | InChI=1S/C20H20O9/c21-12-7-11(8-13(22)9-12)2-1-10-3-5-14(6-4-10)28-20-17(25)15(23)16(24)18(29-20)19(26)27/h1-9,15-18,20-25H,(H,26,27) |
InChIKey | CDEBVTGYVFHDMA-CTAHFCQASA-N |
SMILES | C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)OC3C(C(C(C(O3)C(=O)O)O)O)O |
Reference | <p> |